Ryvu Therapeutics (Poland) Today
Ryvu Therapeutics is selling at 60.00 as of the 25th of November 2024; that is 1.96% down since the beginning of the trading day. The stock's lowest day price was 59.9. Equity ratings for Ryvu Therapeutics SA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of October 2024 and ending today, the 25th of November 2024. Click here to learn more.
Ryvu Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ryvu Therapeutics stock to make a market-neutral strategy. Peer analysis of Ryvu Therapeutics could also be used in its relative valuation, which is a method of valuing Ryvu Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Additional Tools for Ryvu Stock Analysis
When running Ryvu Therapeutics' price analysis, check to measure Ryvu Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ryvu Therapeutics is operating at the current time. Most of Ryvu Therapeutics' value examination focuses on studying past and present price action to predict the probability of Ryvu Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ryvu Therapeutics' price. Additionally, you may evaluate how the addition of Ryvu Therapeutics to your portfolios can decrease your overall portfolio volatility.